Clinical trial
This Record Contains Information About the Mepolizumab Compassionate Use (CU)…
NCT00244686 · GlaxoSmithKline, Industry · No longer available
Key facts
| NCT number | NCT00244686 |
|---|---|
| Title | This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic |
| Official title | 104317: An Open-Label Compassionate Use Access and Long-Term Access Study of Anti IL-5 (Mepolizumab) Treatment in Subjects With Hypereosinophilic Syndrome. 201956: A Long-term Access Programme for Subjects With Severe Asthma Who Participated in a GSK-sponsored Mepolizumab Clinical Study. 112562… |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | No longer available |
| Study type | Expanded Access |
| Conditions | Hypereosinophilic Syndrome |
| Intervention type | Drug |
| Interventions | Mepolizumab |
| First posted | Oct 27, 2005 |
| Last update posted | Apr 25, 2025 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: